Document Detail


Selection of agents for enhanced follicular recruitment in an in vitro fertilization and embryo replacement treatment program.
MedLine Citation:
PMID:  3925848     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In summary, although clomiphene alone, two combinations of clomiphene and hMG, and high dosages of hMG alone all resulted in similar degrees of enhanced follicular recruitment at the time of hCG administration, the patients in the group receiving clomiphene alone had significantly fewer follicles at the time of laparoscopy compared with those of the other three groups. Although clomiphene alone is able to produce sufficient enhanced follicular recruitment, it appears that it is necessary for gonadotropin support to be continued to prevent atresia of some of the cohort of follicles. Second, even though we achieved our best results (with respect to number of embryos replaced per patient) with the use of high-dose hMG, we believe that the ovarian hyperstimulation produced by that regimen resulted in an abnormal luteal phase which made establishment of clinical pregnancies less likely. It is certainly possible that the observed short luteal phases might be able to be corrected with supplemental hCG and/or progesterone. Similar to the results of others, our best results (that is, the highest percentage of the establishment of continuing clinical pregnancies) occurred when the regimen of follicular recruitment agents was individualized depending upon the individual patient's response with respect to size and number of follicles and peripheral E2 levels. However, the differences in pregnancy rates among groups were not statistically significant. Although the ideal regimen for enhanced follicular recruitment has probably not yet been determined, it appears that a combination of clomiphene plus concurrent and sequential hMG in individualized dosages offers the best chance for sufficient ovarian stimulation to ultimately increase the number of embryos available for uterine replacement, and at the same time minimize the disruption of the subsequent luteal phase.
Authors:
M M Quigley
Related Documents :
11950488 - In vitro fertilization in spontaneous cycles--our experience.
7604688 - The success rate in a swedish in-vitro fertilization unit: a cohort study.
6437878 - Diagnosis-specific serum 17 beta-estradiol (e2) upper limits for treatment with menotro...
8612858 - Midluteal buserelin is superior to early follicular phase buserelin in combined gonadot...
11430948 - Transvaginal ultrasound and digital examination in predicting successful labor induction.
14762488 - Results of microsurgical anastomosis in men with seminal tract obstruction due to ingui...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  442     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  1985  
Date Detail:
Created Date:  1985-08-06     Completed Date:  1985-08-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  96-111     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Gonadotropin / therapeutic use
Clinical Trials as Topic
Clomiphene / therapeutic use
Embryo Transfer / methods*
Estradiol / blood
Female
Fertilization in Vitro / drug effects*
Follicle Stimulating Hormone / blood,  therapeutic use
Humans
Luteinizing Hormone / blood
Menotropins / therapeutic use
Menstruation
Oocytes / cytology
Ovarian Follicle / physiology
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 50-28-2/Estradiol; 61489-71-2/Menotropins; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone; 911-45-5/Clomiphene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modification of the nucleolar structure of the rat oocyte observed just before maturation.
Next Document:  AF64A produces long-term cognitive impairments following infusion into the lateral cerebral ventricl...